A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer

Acta Oncologica

Volumn 49, Issue 4, 2010, Pages 480-484

  De Pas, Tommaso ^a   Raimondi, Sara ^a   Pelosi, Giuseppe ^a   Spaggiari, Lorenzo ^a   Braud, Fillipo De ^a   Veronesi, Giulia ^a   Maisonneuve, Patrick ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; DRUG EFFICACY; HUMAN; LUNG NON SMALL CELL CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DECISION MAKING; DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; NEOPLASM STAGING; ONTARIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; PNEUMONECTOMY; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 77951212041     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903490077     Document Type: Review

References (48)

1. Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 2007;25:5506-5518
2. Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Grodzki T, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IBIIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol 2006;7:719-727
3. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-3559
4. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:S225-S233.
5. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classifi cation of malignant tumours. J Thorac Oncol 2007; 2:706-714 (Pubitemid 47357522)
6. Strauss GM, Herndon J E, Maddaus MA. Adjuvant chemotherapy in stage IB non small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 19633. J Clin Oncol 2008;24:S365(Suppl; abstr 7007).
7. Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M, et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol 2005;23:4999-5006. (Pubitemid 46224006)
8. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta- analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899-909.
9. George S, Schell MJ, Detterbeck FC, Socinski MA. Adjuvant chemotherapy for resected non-small cell carcinoma of the lung: Why we still don't know. Oncologist 1998;3:35-44.
10. Bria E, Felici A, Carlini P, Ferretti G, Nistico C, Cuppone F, et al. Adjuvant chemotherapy for non-small cell lung cancer: Pooled analysis of 3443 patients. Ann Oncol 2004;15:A646 (Suppl 3).
11. Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004;22:3860-3867 (Pubitemid 41079866)
12. Sedrakyan A, Van Der MJ, O'Byrne K, Prendiville J, Hill J, Treasure T. Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. J Thorac Cardiovasc Surg 2004;128:414-419
13. Berghmans T, Paesmans M, Meert AP, Mascaux C, Lothaire P, Lafi tte JJ, et al. Survival improvement in resectable nonsmall cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature. Lung Cancer 2005;49:13-23.
14. Bria E, Gralla R, Raftopoulos H, Ferretti G, Felici A, Nistico C, et al. Does adjuvant chemotherapy improve survival in non small cell lung cancer (NSCLC). A pooled-analysis of 6494 patients in 12 studies, examining survival and magnitude of benefi t. J Clin Oncol 2005;23(Suppl):655s.
15. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of fi ve randomized clinical trials including 4,584 patients. J Clin Oncol 2006;24(Suppl): S366.
16. Stewart LA, Burdett S, Tierney JF, Pignon J. Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomized clinical trials (RCT). J Clin Oncol 2007;25(Suppl):S397.
17. Ichinose Y, Hara N, Ohta M, Motohiro A, Kuda T, Aso H. Postoperative adjuvant chemotherapy in non-small cell lung cancer: Prognostic value of DNA ploidy and post-recurrent survival. J Surg Oncol 1991;46:15-20.
18. Niiranen A, Niitamo-Korhonen S, Kouri M, Assendelft A, Mattson K, Pyrhonen S. Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: A randomized study. J Clin Oncol 1992;10:1927-1932
19. Feld R, Rubinstein L, Thomas PA. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group. J Natl Cancer Inst 1993; 85:299-306.
20. Ohta M, Tsuchiya R, Shimoyama M, Sawamura K, Mori T, Miyazawa N, et al. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group. J Thorac Cardiovasc Surg 1993;106:703-708
21. Dautzenberg B, Chastang C, Arriagada R, Le Chevalier T, Belpomme D, Hurdebourcq M, et al. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques). Cancer 1995;76:779-786
22. Lee CG, Kim JH, Chung KY, Lee DY, Kim KD, Lee WY et al. A prospective randomized study of postoperative adjuvant chemo-radiotherapy (CT-RT) vs radiotherapy (RT) alone in resected stage II and IIIA non-small call lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1995;32: 280(Suppl 1).
23. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 2000;343:1217-1222
24. Mineo TC, Ambrogi V, Paci M, Iavicoli N, Pompeo E, Nofroni I. Transxiphoid bilateral palpation in video-assisted thoracoscopic lung metastasectomy. Arch Surg 2001;136: 783-788
25. Lee G-W, Kim S-W, Suh C, Kim WS, Kim DK, Park SI, et al. Prognostic signifi cance of lympho/vascular tumor emboli at adjuvant chemotherapy setting in the patients with stage II, III non-small cell lung cancer after curative resection and postoperative thoracic radiotherapy. Proc Am Soc Clin Oncol 2003;21:649.
26. Scagliotti GV, Fossati R, Torri V, Crino L, Giaccone G, Silvano G, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 2003;95:1453-1461
27. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360 (Pubitemid 38101630)
28. Tada H, Tsuchiya R, Ichinose Y, Koike T, Nishizawa N, Nagai K, et al. A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer 2004; 43:167-173
29. Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352:2589-2597 (Pubitemid 41007845)
30. Park JH, Lee CT, Lee HW, Baek HJ, Zo JI, Shim YM. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2005;27:1086-1091
31. Logan DM, Lochrin CA, Darling G, Eady A, Newman TE, Evans WK. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group. Cancer Prev Control 1997;1:366-378
32. Alam N, Darling G, Evans WK, Mackay JA, Shepherd FA. Adjuvant chemotherapy for completely resected non-small cell lung cancer: A systematic review. Crit Rev Oncol Hematol 2006;58:146-155
33. Alam N, Darling G, Shepherd FA, Mackay JA, Evans WK. Postoperative chemotherapy in nonsmall cell lung cancer: A systematic review. Ann Thorac Surg 2006;81:1926-1936
34. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, et al . A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990;323:940-945
35. Osaka Lung Cancer Study Group. Postoperative adjuvant chemotherapy in non-small cell lung cancer: Results of a prospective randomized study. Jpn J Lung Cancer 1992; 32:11-22.
36. Imaizumi, M. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer. Lung Cancer 1995;49:85-94.
37. Wada H, Hitomi S, Teramatsu T. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J Clin Oncol 1996;14:1048-1054
38. Xu G, Rong T, Lin P. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: A randomized study on 70 patients. Chin Med J (Engl) 2000;113:617-620
39. Waller D, Peake MD, Stephens RJ, Gower NH, Milroy R, Parmar MK, et al. Chemotherapy for patients with non-small cell lung cancer: The surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 2004;26:173-182
40. Tada H, Yasumitu T, Iuchi K, Taki T, Kodama K, Mori T, et al. Randomized study of adjuvant chemotherapy for completely resected non-small cell lung cancer: Lack of prognostic signifi cance in DNA ploidy pattern at adjuvant setting. Proc Am Soc Clin Oncol 2002;21:Abstract 1250.
41. Ueda H, Sakada T, Kuwahara M, Motohiro A. A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected nonsmall cell lung cancer. Anticancer Drugs 2004;15:29-33.
42. Karrer K, Pridun N, Denck H. Chemotherapy as an adjuvant to surgery in lung cancer. Cancer Chemother Pharmacol 1978;1:145-159
43. Israel L, Bonadonna G, Sylvester R. Controlled study with adjuvant radiotherapy, chemotherapy, immunotherapy and chemoimmunotherapy in operable squamous carcinoma of the lung. In: Muggia F, Rozencweig M, editors. Lung cancer: Progress in therapeutic research. New York: Raven Press; 1979. pp. 443-452
44. Shields TW, Higgins GAJ, Humphrey EW, Matthews MJ, Keehn RJ. Prolonged intermittent adjuvant chemotherapy with CCNU and hydroxyurea after resection of carcinoma of the lung. Cancer 1982;50:1713-1721
45. Girling DJ, Stott H, Stephens RJ, Fox W. Fifteen-year followup of all patients in a study of post-operative chemotherapy for bronchial carcinoma. Br J Cancer 1985;52:867-873
46. Schallier DC, De Neve WJ, De Greve JL, Van Belle SP, De Wasch GJ, Dotremont G, et al. Is adjuvant treatment with vinblastine effective in reducing the occurrence of distant metastasis in limited squamous cell lung cancer? A randomized study. Clin Exp Metastasis 1988;6:39-48.
47. Trachtenberg A, Zakharchenkov AV, Zhiclov MA. Combined treatment including postoperative chemotherapy in lung cancer patients. Neoplasma 1988;35:351-359
48. The Lung Cancer Study Group. The benefi t of adjuvant treatment for resected locally advanced non-small-cell lung cancer. J Clin Oncol 1988;6:9-17.